2024-11-29 12:35:28
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis
Corporate/ 2023-07-24
Everest Medicines' Licensing Partne...

SHANGHAI,May 24,2022-- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner,Pfizer Inc. (NYSE: PFE) presented at Dige...

Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis
Corporate/ 2023-07-24
Everest Medicines' Licensing Partne...

SHANGHAI,May 24,2022-- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner,Pfizer Inc. (NYSE: PFE) presented at Dige...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release